• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

A research agenda for curing chronic hepatitis B virus infection.

作者信息

Alter Harvey, Block Timothy, Brown Nathaniel, Brownstein Alan, Brosgart Carol, Chang Kyong-Mi, Chen Pei-Jer, Chisari Francis V, Cohen Chari, El-Serag Hashem, Feld Jordan, Gish Robert, Glenn Jeffrey, Greten Tim, Guo Haitao, Guo Ju-Tao, Hoshida Yujin, Hu Jianming, Kowdley Kris V, Li Wenhui, Liang Jake, Locarnini Stephan, Lok Anna S, Mason William, McMahon Brian, Mehta Anand, Perrillo Robert, Revill Peter, Rice Charles M, Rinaudo JoAnn, Schinazi Raymond, Seeger Christoph, Shetty Kirty, Tavis John, Zoulim Fabien

机构信息

Clinical Center, National Institutes of Health, Bethesda, MD.

Hepatitis B Foundation and Baruch S. Blumberg Institute, Doylestown, PA.

出版信息

Hepatology. 2018 Mar;67(3):1127-1131. doi: 10.1002/hep.29509. Epub 2018 Jan 24.

DOI:10.1002/hep.29509
PMID:28877549
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5873273/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f0e/5873273/22ebee62960f/HEP-67-1127-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f0e/5873273/22ebee62960f/HEP-67-1127-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f0e/5873273/22ebee62960f/HEP-67-1127-g001.jpg

相似文献

1
A research agenda for curing chronic hepatitis B virus infection.治愈慢性乙型肝炎病毒感染的研究议程。
Hepatology. 2018 Mar;67(3):1127-1131. doi: 10.1002/hep.29509. Epub 2018 Jan 24.
2
The current status and future directions of hepatitis B antiviral drug discovery.乙肝抗病毒药物研发的现状与未来方向
Expert Opin Drug Discov. 2017 Jan;12(1):5-15. doi: 10.1080/17460441.2017.1255195. Epub 2016 Nov 11.
3
Five-year data released for entecavir.
AIDS Patient Care STDS. 2008 Apr;22(4):349. doi: 10.1089/apc.2008.9956.
4
[Hepatitis B virus resistance to entecavir].[乙型肝炎病毒对恩替卡韦的耐药性]
Med Clin (Barc). 2012 Jul 21;139(5):228-9. doi: 10.1016/j.medcli.2012.01.005. Epub 2012 Mar 6.
5
Antiviral strategies to eliminate hepatitis B virus covalently closed circular DNA (cccDNA).消除乙肝病毒共价闭合环状DNA（cccDNA）的抗病毒策略。
Curr Opin Pharmacol. 2016 Oct;30:144-150. doi: 10.1016/j.coph.2016.08.015.
6
COLD-PCR for early detection of hepatitis B virus antiviral drug resistance mutations.
Hong Kong Med J. 2015 Dec;21 Suppl 7:S8-10.
7
[The genetic variability and clinical significance of hepatitis B virus].[乙型肝炎病毒的基因变异性及临床意义]
Zhonghua Gan Zang Bing Za Zhi. 2009 Mar;17(3):161-3.
8
[Therapy for chronic hepatitis B: relationship between HBV genotype and efficacy or resistance of anti-viral therapy].[慢性乙型肝炎的治疗：HBV 基因型与抗病毒治疗疗效或耐药性之间的关系]
Nihon Shokakibyo Gakkai Zasshi. 2007 Oct;104(10):1459-64.
9
Potential Drug Targets Against Hepatitis B Virus Based on Both Virus and Host Factors.基于病毒和宿主因素的潜在抗乙型肝炎病毒药物靶点
Curr Drug Targets. 2019;20(16):1636-1651. doi: 10.2174/1389450120666190729115646.
10
[Focusing on the markers for monitoring and antiviral therapy in chronic hepatitis B virus infection].[聚焦慢性乙型肝炎病毒感染的监测及抗病毒治疗标志物]
Zhonghua Gan Zang Bing Za Zhi. 2006 Nov;14(11):836-7.

引用本文的文献

1
Interferon Lambda: The Next Frontier in Antiviral Therapy?干扰素λ：抗病毒治疗的新前沿？
Pharmaceuticals (Basel). 2025 May 24;18(6):785. doi: 10.3390/ph18060785.
2
Epigenetic drugs against human DNA viruses and retroviruses.针对人类DNA病毒和逆转录病毒的表观遗传药物。
Antiviral Res. 2025 Aug;240:106218. doi: 10.1016/j.antiviral.2025.106218. Epub 2025 Jun 23.
3
Host 3' flap endonuclease Mus81 plays a critical role in trimming the terminal redundancy of hepatitis B virus relaxed circular DNA during covalently closed circular DNA formation.

本文引用的文献

1
A historical perspective on the discovery and elucidation of the hepatitis B virus.关于乙型肝炎病毒发现与阐明的历史视角。
Antiviral Res. 2016 Jul;131:109-23. doi: 10.1016/j.antiviral.2016.04.012. Epub 2016 Apr 20.
2
Annual Report to the Nation on the Status of Cancer, 1975-2012, featuring the increasing incidence of liver cancer.《1975 - 2012年美国癌症现状年度报告》，重点关注肝癌发病率上升情况
Cancer. 2016 May 1;122(9):1312-37. doi: 10.1002/cncr.29936. Epub 2016 Mar 9.
3
Global strategies are required to cure and eliminate HBV infection.
宿主3' 瓣状核酸内切酶Mus81在共价闭合环状DNA形成过程中修剪乙型肝炎病毒松弛环状DNA的末端冗余方面发挥着关键作用。
PLoS Pathog. 2025 Feb 6;21(2):e1012918. doi: 10.1371/journal.ppat.1012918. eCollection 2025 Feb.
4
The loss of hepatitis B virus receptor NTCP/SLC10A1 in human liver cancer cells is due to epigenetic silencing.乙型肝炎病毒受体 NTCP/SLC10A1 在人肝癌细胞中的丢失是由于表观遗传沉默所致。
J Virol. 2024 Oct 22;98(10):e0118724. doi: 10.1128/jvi.01187-24. Epub 2024 Sep 19.
5
A Particle Gel Assay for Detection of Intracellular Hepatitis B Virus Subviral Particles in Cultured Cells.一种用于检测细胞内乙型肝炎病毒亚病毒颗粒的粒子凝胶检测法。
Methods Mol Biol. 2024;2837:89-97. doi: 10.1007/978-1-0716-4027-2_8.
6
Tripartite Motif-Containing Protein 65 (TRIM65) Inhibits Hepatitis B Virus Transcription.三结构域蛋白 65（TRIM65）抑制乙型肝炎病毒转录。
Viruses. 2024 May 31;16(6):890. doi: 10.3390/v16060890.
7
HOXA-AS2 Epigenetically Inhibits HBV Transcription by Recruiting the MTA1-HDAC1/2 Deacetylase Complex to cccDNA Minichromosome.HOXA-AS2 通过募集 MTA1-HDAC1/2 去乙酰化酶复合物到cccDNA 微染色体抑制 HBV 转录。
Adv Sci (Weinh). 2024 Jun;11(24):e2306810. doi: 10.1002/advs.202306810. Epub 2024 Apr 22.
8
An allosteric inhibitor of sirtuin 2 blocks hepatitis B virus covalently closed circular DNA establishment and its transcriptional activity.一种 Sirtuin 2 的别构抑制剂可阻断乙型肝炎病毒共价闭合环状 DNA 的建立及其转录活性。
Antiviral Res. 2024 Jun;226:105888. doi: 10.1016/j.antiviral.2024.105888. Epub 2024 Apr 18.
9
Special Issue "Hepatitis B Virus: New Breakthroughs to Conquer an Ancient Disease".特刊征稿：乙型肝炎病毒：攻克古老疾病的新突破
Viruses. 2023 Oct 30;15(11):2173. doi: 10.3390/v15112173.
10
The hepatitis B virus pre-core protein p22 suppresses TNFα-induced apoptosis by regulating the NF-κB pathway.乙肝病毒前核心蛋白p22通过调节核因子κB通路抑制肿瘤坏死因子α诱导的细胞凋亡。
Am J Transl Res. 2023 Aug 15;15(8):5184-5196. eCollection 2023.
需要采取全球策略来治愈和消除乙肝病毒感染。
Nat Rev Gastroenterol Hepatol. 2016 Apr;13(4):239-48. doi: 10.1038/nrgastro.2016.7. Epub 2016 Feb 24.
4
Present and future therapies of hepatitis B: From discovery to cure.乙型肝炎的当前及未来疗法：从发现到治愈
Hepatology. 2015 Dec;62(6):1893-908. doi: 10.1002/hep.28025. Epub 2015 Oct 27.
5
Molecular biology of hepatitis B virus infection.乙型肝炎病毒感染的分子生物学
Virology. 2015 May;479-480:672-86. doi: 10.1016/j.virol.2015.02.031. Epub 2015 Mar 7.
6
Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity.全球乙型肝炎病毒感染流行病学：特定年龄 HBsAg 血清流行率和地方性的新估计。
Vaccine. 2012 Mar 9;30(12):2212-9. doi: 10.1016/j.vaccine.2011.12.116. Epub 2012 Jan 24.
7
Natural history of chronic hepatitis B.慢性乙型肝炎的自然史。
Clin Liver Dis. 2010 Aug;14(3):381-96. doi: 10.1016/j.cld.2010.05.007.
8
Hepatitis B virus immunopathogenesis.乙型肝炎病毒免疫发病机制
Annu Rev Immunol. 1995;13:29-60. doi: 10.1146/annurev.iy.13.040195.000333.